a developer of therapies to degrade disease-causing proteins
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.
Ticker / NAME | Correlation To ARVN | 1D Price Change % | ||
---|---|---|---|---|
ARVN | 100% | -3.69% | ||
ABCL - ARVN | 53% Loosely correlated | -1.35% | ||
CRBU - ARVN | 50% Loosely correlated | -6.18% | ||
IPSC - ARVN | 50% Loosely correlated | -5.67% | ||
KYMR - ARVN | 46% Loosely correlated | -2.74% | ||
BEAM - ARVN | 43% Loosely correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To ARVN | 1D Price Change % |
---|---|---|
ARVN | 100% | -3.69% |
cancer theme (82 stocks) | 48% Loosely correlated | -2.38% |
drugs theme (254 stocks) | 40% Loosely correlated | -1.72% |
fighting cancer theme (12 stocks) | 39% Loosely correlated | -2.28% |
therapy theme (23 stocks) | 39% Loosely correlated | -3.41% |
diseases theme (41 stocks) | 35% Loosely correlated | -1.18% |
More |